SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $539,000 | -3.9% | 7,186 | 0.0% | 0.04% | +28.6% |
Q1 2022 | $561,000 | -13.3% | 7,186 | 0.0% | 0.03% | -3.4% |
Q4 2021 | $647,000 | -2.7% | 7,186 | 0.0% | 0.03% | -6.5% |
Q3 2021 | $665,000 | +19.0% | 7,186 | 0.0% | 0.03% | +29.2% |
Q2 2021 | $559,000 | +4.3% | 7,186 | -0.0% | 0.02% | -4.0% |
Q1 2021 | $536,000 | -88.4% | 7,187 | -78.2% | 0.02% | -91.0% |
Q3 2020 | $4,624,000 | -12.4% | 32,931 | +0.0% | 0.28% | -15.2% |
Q2 2020 | $5,279,000 | +37.9% | 32,926 | -15.9% | 0.33% | +26.2% |
Q1 2020 | $3,828,000 | -24.2% | 39,132 | +0.0% | 0.26% | +9.2% |
Q4 2019 | $5,049,000 | +71.3% | 39,129 | +0.0% | 0.24% | +83.1% |
Q3 2019 | $2,947,000 | -50.4% | 39,126 | 0.0% | 0.13% | -44.0% |
Q2 2019 | $5,945,000 | +27.5% | 39,126 | 0.0% | 0.23% | +18.4% |
Q1 2019 | $4,663,000 | +194.8% | 39,126 | +169.8% | 0.20% | +145.0% |
Q4 2018 | $1,582,000 | -8.0% | 14,500 | -37.5% | 0.08% | +31.1% |
Q1 2018 | $1,719,000 | +33.2% | 23,200 | 0.0% | 0.06% | +52.5% |
Q4 2017 | $1,291,000 | – | 23,200 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |